Piramal Pharma strengthens board by inducting three new board members
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The combined company will be able to better serve both our global and regional customers with local production
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Strengthens investment in channels of the future to expand patient reach
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Subscribe To Our Newsletter & Stay Updated